Pharmabiz1h
Lipella Pharma receives US FDA nod for expanded access programme for LP-310, an oral rinse formulation to treat oral lichen planus
Lipella Pharma receives US FDA nod for expanded access programme for LP-310, an oral rinse formulation to treat oral lichen planus: Pittsburgh Saturday, February 8, 2025, 09:00 Hr ...
Pharmabiz2h
TN IPA starts training programme for B Pharm & M Pharm students to be appointed in manufacturing companies
Peethaambaran Kunnathoor, Chennai Saturday, February 8, 2025, 08:00 Hrs [IST] ...
Pharmabiz2h
Advanced therapies, medicines bring new hope for pulmonary hypertension patients: Dr Manisha Mendiratta
Advanced therapies, medicines bring new hope for pulmonary hypertension patients: Dr Manisha Mendiratta: Shardul Nautiyal, Mumbai Saturday, February 8, 2025, 08:00 Hrs [IST] Dr Ma ...
Pharmabiz2h
OET paves the way for global healthcare careers: Amit Upadhyay
Amit Upadhyay: Shardul Nautiyal, Mumbai Saturday, February 8, 2025, 08:00 Hrs [IST] For Indian doctors, nurses, and pharmacists as ...
Pharmabiz2h
India needs to develop strategies to mitigate the impact of USAID funding freeze
India needs to develop strategies to mitigate the impact of USAID funding freeze: Nandita Vijayasimha, Bengaluru Saturday, February 8, 2025, 08:00 Hrs [IST] Indian pharmaceutical ...
Pharmabiz2h
Budget allocation to DHR witness 40% increase in FY26
The proposed budget allocation for the Central sector schemes of Department of Health Research (DHR), under the ministry of health and family welfare, is expected see an increase of almost 40 per cent ...
Pharmabiz16h
Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke
Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...
Pharmabiz17h
Essential Pharma & Clinigen expand collaboration to improve patient access in JAPAC
Essential Pharma & Clinigen expand collaboration to improve patient access in JAPAC: Egham, UK Friday, February 7, 2025, 17:00 Hrs [IST] Essential Pharma, an international special ...
Pharmabiz18h
Actimed Therapeutics’ anti-catabolic and pro-anabolic transforming agent, S-pindolol benzoate receives US & European patents
Actimed Therapeutics’ anti-catabolic and pro-anabolic transforming agent, S-pindolol benzoate receives US & European patents: London, UK Friday, February 7, 2025, 16:00 Hrs [IST ...
Pharmabiz19h
CIRM awards US$ 4 mn grant to Entos Pharma to advance development of ENTLEP001, a durable and redosable genetic medicine to treat CGL
CIRM awards US$ 4 mn grant to Entos Pharma to advance development of ENTLEP001, a durable and redosable genetic medicine to treat CGL: San Diego Friday, February 7, 2025, 15:00 Hr ...
Pharmabiz21h
Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay
Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay: Salt Lake City Friday, February 7, 2025, 13:00 Hrs [IST] Myriad Genetics, Inc., a ...
Pharmabiz22h
Sanofi in partnership with Regeneron to present 24 abstracts across approved and investigational medicines at AAAAI Annual Meeting in San Diego
Sanofi in partnership with Regeneron to present 24 abstracts across approved and investigational medicines at AAAAI Annual Meeting in San Diego: Paris Friday, February 7, 2025, 12 ...